Heating the patient: A promising approach?

Annals of Oncology

Volumn 13, Issue 8, 2002, Pages 1173-1184

  van der Zee, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chemosensitisation; Heating techniques; Hyperthermia; Improved clinical results; Radiosensitisation

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTOTOXIC AGENT; ETOPOSIDE; HEAT SHOCK PROTEIN; IFOSFAMIDE; OXYGEN; ANTINEOPLASTIC AGENT;

BLADDER CANCER; BONE MARROW PURGING; BRAIN CANCER; BREAST CANCER; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; ENERGY RESOURCE; ESOPHAGUS CANCER; GENE THERAPY; HEAD AND NECK CANCER; HUMAN; HYPERTHERMIC THERAPY; IMMUNE RESPONSE; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; OXYGEN TENSION; PH; PRIORITY JOURNAL; RADIATION INJURY; RECTUM CANCER; REVIEW; SIDE EFFECT; TEMPERATURE; THERMOMETRY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER; BODY TEMPERATURE; CLINICAL TRIAL; MULTIMODALITY CANCER THERAPY; NEOPLASM;

ANTINEOPLASTIC AGENTS; BODY TEMPERATURE; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMAN; HYPERTHERMIA, INDUCED; NEOPLASMS; HUMANS;

EID: 0036668656     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf280     Document Type: Review

References (114)

1. A historical perspective on hyperthermia in oncology
2. Tumour microcirculation as a target for hyperthermia
3. Microvasculature and perfusion in normal tissues and tumours
4. Metabolic status and reaction to heat of normal and tumor tissue
5. Fundamental aspects of hyperthermic biology
6. Pathological effects of hyperthermia in normal tissues
7. Effect of hyperthermia on the central nervous system: O review
8. Effects of local hyperthermia on the motor function of the rat sciatic nerve
9. Molecular and cellular mechanisms of hyperthermia
10. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen
11. Hyperthermic radiosensitization: Mode of action and clinical relevance
12. The therapeutic advantage of combined heat and X-rays on a mouse fibrosarcoma
13. Combined radiation and hyperthermia: Effects of the number of heat fractions and their interval on normal and tumour tissues
14. Simultaneous and sequential treatment with radiation and hyperthermia: A comparative assessment
15. Interaction of heat and drugs in vitro and in vivo
16. Altered hepatic disposition of doxorubicin in the perfused rat liver at hyperthermic temperatures
17. Cyclophosphamide pharmacokinetics in patients receiving whole-body hyperthermia
18. The effect of systemic hyperthermia on melphalan pharmacokinetics in mice
19. The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro
20. Hyperthermia
21. Hyperthermic isolation limb perfusion for malignant melanoma: A review
22. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intraabdominal cancer
23. A nontoxic system for 41.8°C whole-body hyperthermia: Results of a phase I study using a radiant heat device
24. Clinical practice of whole-body hyperthermia: New directions
25. Selective heat sensitivity of cancer cells. Biochemical and clinical studies
26. Clinical effects of whole-body hyperthermia in advanced malignancy
27. Local tumor hyperthermia in combination with radiation therapy. 1. Malignant cutaneous lesions
28. Combined treatment with radiation and hyperthermia in metastatic malignant melanoma
29. Interactions of hyperthermia with other modalities
30. Clinical hyperthermia: Results of a phase I trial employing hyperthermia alone or in combination with external beam or interstitial radiotherapy
31. An assessment of local hyperthermia in clinical practice
32. Hyperthermia alone in the treatment of recurrences of malignant tumors
33. Low dose reirradiation in combination with hyperthermia: A palliative treatment for patients with breast cancer recurring in previously irradiated areas
34. The current and potential role of hyperthermia in radiotherapy
35. Thermoradiotherapy for advanced and recurrent breast tumours
36. Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation
37. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix
38. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix
39. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: Long-term results of a phase II study
40. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia
41. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer
42. Ifosfamide, carboplatin and etoposid (ICE) combined with 41.8°C whole body hyperthermia in patients with refractory sarcoma
43. Thermoradiotherapy and thermochemotherapy for pediatric tumors
44. Hyperthermia for the treatment of patients with malignant germ cell tumors. A phase I/II study in ten children and adolescents with recurrent or refractory tumors
45. Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: A report by the Radiation Therapy Oncology Group
46. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors
47. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by Oncology Group
48. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial
49. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients
50. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma
51. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials
52. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost±hyperthermia for glioblastoma multiforme
53. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial
54. Thermoradiotherapy of patient with locally advanced carcinoma of the rectum
55. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer
56. Thermoradiotherapy in the management of carcinoma cervix (stage IIIb): A controlled clinical study
57. A randomized clinical trial of hyperthermia and radiation versus radiation alone for superficially located cancers
58. Clinical studies in whole body hyperthermia
59. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIb cervical carcinoma
60. Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs
61. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma
62. Thermochemotherapy (TC) for gynecologic malignancies
63. Combined therapy of bladder cancer with the use of hyperthermia
64. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus: A prospective randomized trial
65. Intracavitary microwave hyperthermia combined with external irradiation in the treatment of esophageal cancer
66. Combination preoperative radiation and endocavitary hyperthermia for rectal cancer: Long-term results of 44 patients
67. Head and neck cancers: Results of thermoradiotherapy versus radiotherapy
68. Combined radiation and hyperthermia in superficial human tumors
69. A prospective randomized study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy
70. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma
71. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial
72. Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: Prognostic factors in 196 tumors
73. Radiofrequency capacitive hyperthermia for deep-seated tumors II. Effect of thermoradiotherapy
74. Clinical experience using 8 MHz radiofrequency capacitive hyperthermia in combination with radiotherapy: Results of a phase I/II study
75. Clinical, physiological and anatomical determinants for radiofrequency hyperthermia
76. Clinical practice of hyperthermic extremity perfusion in combination with radiotherapy and chemotherapy
77. The Dutch Deep Hyperthermia Trial: Results in cervical cancer
78. Design and test of a new multi-amplifier system with phase and amplitude control
79. A 433 MHz Lucite Cone waveguide applicator for superficial hyperthermia
80. Comparison of the clinical effectiveness of the 433 MHz Lucite Cone applicator with that of a conventional waveguide applicator in applications of superficial hyperthermia
81. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia
82. Simulation studies promote technological development of radiofrequency phased array hyperthermia
83. Hyperthermia treatment planning
84. Clinical evaluation and verification of the hyperthermia treatment planning system Hyperplan
85. Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma
86. Fast spectroscopic imaging for non-invasive thermometry using the Pr[MOE-DO3A] complex
87. Selective delivery of liposome-associated cis-Dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth
88. Hyperthermia increases accumulation of Technetium-99M-labeled liposomes in feline sarcomas
89. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release
90. A stress-indcible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells
91. CD-3 large granular lymphocytes recognize a heat-inducible immunogenic determinant associated with the 72-kD heat shock protein on human sarcoma cells
92. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway
93. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia
94. Heat-inducible vectors for use in gene therapy
95. Heat-induced gene expression as a novel targeted cancer gene therapy strategy
96. Adnovirus-mediated transfer of p53 augments hyperthermia-induced apoptosis in U251 glioma cells
97. Enhancement of radiotherapy by hyperthermia-regulated gene therapy
98. Bone marrow experts are still debating the value of purging
99. Application of hyperthermia to the treatment of human acute leukemia: Purging human leukemic progenitor cells by heat
100. Hyperthermic purging in vitro of murine leukemia cells (MK-8057): Surviving fractions of normal and leukemic stem cells and the long-term survival of mice injected with the post-hyperthermic leukemia cells
101. Enhanced elimination of Ph+ chormosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-α, TNF, and quercetin): Its application to autologous bone marrow transplantation for CML
102. Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: Enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH[3]
103. A novel drug to reduce tumor perfusion: Antitumor effect alone and with hyperthermia
104. Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation
105. Vinblastine and hyperthermia target the neovasculature in BT4AN rat gliomas: Therapeutic implications of the vascular phenotype
106. Combrestatin A-4 and hyperthermia; a potent combination for the treatment of solid tumors
107. Heat, drugs and radiation given in combination is palliative for unresectable esophageal cancer
108. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum
109. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer. A phase II clinical study
110. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer
111. Radiation therapy, cisplatin and hyperthermia in combination in management of patients with carcinomas of the head and neck with N2 or N3 metastatic cervical lymph nodes
112. Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease
113. Introduction